Serum ribonuclease in patients with lung carcinoma
β Scribed by Patrick C. Marabella; George L. Tritsch; Robert H. Moore; Hiroshi Takita
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 250 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Fiftyβone previously untreated cases of lung carcinoma and 7 normal healthy controls were evaluated with respect to serum ribonuclease (SβRNase) levels. Cellular immunity was tested in 22 of these 51 cases by leukocyte migration inhibition test (MIT) using extract of culture cell line of lung carcinoma.
SβRNase levels in lung carcinomas were significantly elevated. There appeared to be no difference in SβRNase levels by histological classification. More striking was high SβRNase level in disseminated versus localized cases. MIT results indicated impairment of cellular immunity in those cases of more elevated SβRNase. SβRNase may be implicated in blocking phenomenon associated with neoplastic disease.
π SIMILAR VOLUMES
The specific activity of urinary hexosaminidase was determined in 58 patients with various histological types of lung carcinoma, Compared to an apparently healthy control population, 32/35 patients with widely disseminated disease showed elevated values and 18/23 patients with disease confined to th
There are only limited population-based data available regarding the risk of developing a second cancer after a diagnosis of lung carcinoma. ## METHODS. Data collected from the Cancer Registry of the Swiss Canton of Vaud (comprised of approximately 600,000 inhabitants) were used to estimate the i
13 adolescent patients with mucin-producing colorectal adenocarcinoma were treated at a Memphis, Tennessee, pediatric oncology center. Ten of these children were from the rural areas of the Mississippi Delta, areas of high pesticide use. None of them had a family history of colorectal cancer, famili